ClinicalTrials.gg

Program

urinastatin

Also written as “Ulinastatin” and “ulinastatin”.

Its studies are mostly in Respiratory Distress Syndrome · Pancreatitis · Heart Defects, Congenital, led by Shanghai Pharmaceuticals.

Furthest: phase 4, since May 26, 20104 company-led studies, 1 open or runningNext primary completion: Mar 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Shanghai Pharmaceuticals41 open or runningphase 4since May 26, 2010May 26, 2010Mar 2027phase 1 · NCT07923578

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. May 26, 2010First study: phase 4 study in PancreatitisFirst studyNCT01132521 · 252 enrolled · China
  2. Dec 18, 2014Phase 4 study in Heart Defects, CongenitalNCT02527811 · 450 enrolled · China
  3. Jul 21, 2016Phase 2 study in Respiratory Distress SyndromeNCT02895191 · 60 enrolled · China
  4. Oct 21, 2026Phase 1 study in Healthy ParticipantsNCT07923578 · 40 planned · China

Ahead

  1. Mar 2027Primary completion: phase 1 study in Healthy ParticipantsNCT07923578

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07923578Healthy Participants · China1Not yet recruitingMar 202740
NCT02895191Respiratory Distress Syndrome · China2UNKNOWNSep 201960
NCT02527811Heart Defects, Congenital · China4UNKNOWNJun 2018450
NCT01132521Pancreatitis · China4SuspendedDec 2018252

How it is read

Names in the registry

  • “Ulinastatin”, 2 entries
  • “ulinastatin”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.